[1]
Mazurek, M. et al. 2023. Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Journal of Education, Health and Sport. 13, 4 (Feb. 2023), 123–131. DOI:https://doi.org/10.12775/JEHS.2023.13.04.013.